Prague, Czechia

Iva Matunova

This inventor holds 1 USPTO granted patent. Top assignee: Spofa, Spojene Podinky Pro Zdravotnickou Vyrobu. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iva Matunova. Retrieved from https://idiyas.com/inventor/iva-matunova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Iva Matunova: Innovator in Antimycotic Compounds

Introduction

Iva Matunova is a notable inventor based in Prague, Czech Republic. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antimycotic properties. Her work is essential for advancing treatments for various mycoses.

Latest Patents

Iva Matunova holds a patent for "Imidazole thieno-benzothiepins." This invention relates to imidazolyl thieno-benzothiepin derivatives and their acid addition salts, which are useful in treating dermal and vaginal mycoses. The compounds demonstrate substantial in vitro and in vivo antimycotic properties. The preparation of these compounds involves specific chemical reactions, showcasing her expertise in medicinal chemistry.

Career Highlights

Iva Matunova is associated with Spofa, Spojene Podinky Pro Zdravotnickou Vyrobu, where she has been instrumental in research and development. Her innovative approach has led to the creation of effective pharmaceutical solutions.

Collaborations

Iva collaborates with talented coworkers, including Jan Leiner and Vladislava Hola. Their combined efforts contribute to the advancement of research in the pharmaceutical industry.

Conclusion

Iva Matunova's work in developing antimycotic compounds highlights her significant role in the pharmaceutical field. Her innovative contributions continue to impact the treatment of mycoses, showcasing the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…